Complement receptor 2 (CR2/CD21) is predominantly expressed on the surface of mature B cells where it forms part of a coreceptor complex that functions, in part, to modulate B-cell receptor signal strength. CR2/CD21 expression is tightly regulated throughout B-cell development such that CR2/CD21 cannot be detected on pre-B or terminally differentiated plasma cells. CR2/CD21 expression is upregulated at B-cell maturation and can be induced by IL-4 and CD40 signaling pathways. We have previously characterized elements in the proximal promoter and first intron of CR2/CD21 that are involved in regulating basal and tissue-specific expression. We now extend these analyses to the CR2/CD21 core promoter. We show that in mature B cells, CR2/CD21 transcription proceeds from a focused TSS regulated by a non-consensus TATA box, an initiator element and a downstream promoter element. Furthermore, occupancy of the general transcriptional machinery in pre-B versus mature B-cell lines correlate with CR2/CD21 expression level and indicate that promoter accessibility must switch from inactive to active during the transitional B-cell window.
INTRODUCTION
Human complement receptor 2 (CR2/CD21) is predominantly expressed on the surface of mature B cells and follicular dendritic cells.
1,2 At the cell surface, CR2/CD21 forms the ligand binding component 3, 4 of the B-cell receptor coreceptor complex. Upon interaction with ligands iC3b, C3d, C3dg and the Epstein-Barr virus (EBV) 3, 5 the CR2/CD21-CD19 coreceptor complex crosslinks with the B-cell receptor leading to a 10-to 1000-fold decrease in the threshold for B-cell activation. [6] [7] [8] In mice, Cr2/CD21 expression is first evident at low levels on late-immature B cells exiting the bone marrow, a critical checkpoint for B-cell autoreactivity, and Cr2/CD21 expression increases with B-cell maturation.
1,9 Following B-cell activation and differentiation, Cr2/CD21 is downregulated and is not detected on plasma cells. 10, 11 In this window, Cr2/CD21 expression varies according to the stage of B-cell development and differentiation, with the highest level of expression observed on marginal zone B cells and B10 cells. 12 The major population of mature B cells, follicular B cells, expresses an intermediate level of Cr2/CD21 that fluctuates according to immunogenic challenge. 13 Research conducted in mouse models has been integral to the current understanding of B-cell development. However, there are important differences in CR2/CD21 between mouse and human (reviewed in Ref. 14) . In mice, two proteins Cr2/CD21 and Cr1/CD35 are transcribed by alternative splicing of the Cr2/CD21 gene. 15 In humans, CR1/CD35 is transcribed from a separate downstream gene and therefore, human CR2/CD21 and CR1/CD35 may have additional functions compared to their mouse counterparts.
Aberrant regulation of CR2/CD21 is observed in systemic lupus erythematosus, an inflammatory autoimmune disorder of the connective tissue involving production of auto-antibodies to DNA and chromatin in more than 90% of patients. 16 B cells derived from systemic lupus erythematosus patients express increased CD19 and decreased CR2/CD21 compared to healthy controls. [17] [18] [19] Further, the appropriate restriction and regulation of CR2/CD21 expression is critical to the development of a healthy B-cell repertoire. Transgenic mice expressing human CR2/CD21 at the pre/pro stage of B-cell development in the bone marrow develop B cells with reduced antigen responses, potentially driven by impaired B-cell activation and B-cell receptor-dependent signaling. 20, 21 This implies that timing of CR2/CD21 expression is critical to shaping a functional B-cell repertoire, however the mechanisms driving CR2/CD21 expression during B lymphopoiesis are not defined.
Signaling via CD40 and IL-4 has been shown to increase surface density of CR2/CD21 by 20%-30% and activate the cAMP pathway in human B lymphocytes. 22, 23 The inducible expression of CR2/CD21 is mediated through elements in the CR2/CD21 proximal and core promoter. Previously we have identified various elements that regulate the basal and cellspecific expression of CR2/CD21 in the proximal promoter and first intron respectively. 24, 25 Important regulatory regions include an SP1 site located at 2120 and two functionally distinct E-boxes located between 247 and 260 relative to the transcriptional start site (TSS). 25 Recent studies have attributed the core promoter with a more complex role in regulation of gene expression. [26] [27] [28] [29] The concepts that have emerged are that core promoters are tailored to their biological function and act as the convergence point for long-range and cis-acting regulators of transcription. In the experiments outlined in this report, we assessed the role of the CR2/CD21 core promoter in driving transcription initiation in B cells. We identified a single major transcription initiation site in two mature B-cell lines and demonstrated that general transcriptional machinery occupancy surrounding the TSS correlates with CR2/CD21 expression level in vivo. Moreover, we identified functional regulatory elements in the core promoter that modulate transcriptional activity in vitro including a TATA box, initiator element (Inr), downstream promoter element (DPE), SP1 binding site and a functional single nucleotide polymorphism (SNP).
MATERIALS AND METHODS

Cell culture
Suspension cell lines Reh (CRL-8286), Ramos (CRL-1596), Raji (CCL-86), SKW 6.4 (TIB-215) and K562 (CCL-243) were obtained from ATCC (ATCC, Manassas, VA, USA) and were maintained at 37 uC with 5% CO 2 in RPMI-1640 supplemented with 10% FBS 50 U/ml penicillin and 50 mg/ml streptomycin. We selected cell lines blocked at various stages of development to represent pre-B (Reh), 30 mature-B (Ramos, Raji), 31 terminally differentiated-B (SKW 6.4) 32 or erythroid precursor (K562) 33 cells.
Chromatin immunoprecipitation (ChIP) ChIP was performed as described 34 with Protein A/G Agarose/ Salmon sperm DNA (Upstate Biotechnology, Lake Placid, NY, USA) and 5 mg of a-SP1 (ab13370; Abcam, Milton, Cambridge, UK), a-TBP (ab63766; Abcam), a-RNA polymerase (RNAP) II CTD YSPTSPS phosphoS2 (ab5095; Abcam), a-RNAP II CTD YSPTSPS phosphoS5 (ab5131; Abcam), a-E12 (Sc-762X; Santa Cruz Biotechnology, Dallas, TX, USA), a-E47 (sc-763X; Santa Cruz) or IgG (ab554121; Abcam) (BD Pharmingen, San Jose, CA, USA). Quantitative PCR utilized 2 ml of ChIP samples and the Illumina Eco Real-Time PCR system V.4 (Illumina, San Diego, CA, USA). Primers spanning the 242/1139 portion of the CR2/CD21 promoter (forward 59-CGTGTGCCGGA-CACTATTT-39 and reverse 59-GGTGCGACGAGAGCCAAG-AA-39, annealing temperature 60 uC) were used to detect specific enrichment across the CR2/CD21 TSS. Primers spanning the 28/1291 portion of the CR2/CD21 gene (forward 59-GCT-CACAGCTGCTTGCTGCT-39 and reverse 59-GGTCCCTCA-AAGCTAGCGGGAGGCG-39, annealing temperature 60 uC) were used to detect specific enrichment across the CR2/CD21 DPE. Serially diluted chromatin input (10%-0.01%) was used to construct a standard curve against which samples were quantified. Specific enrichment generated by immune complexes was normalized to the background enrichment generated by the isotype control. Amplicons from a representative qPCR for each experiment were run on a 1.5% agarose gel stained with ethidium bromide for visualization to ensure specificity and correct amplicon size.
Electrophoretic mobility shift assay (EMSA) Protein-DNA binding reactions utilized 2-4 mg of cell line nuclear extract (Thermo FISHER Scientific, Scoresby, VIC, Australia) in chilled binding buffer(4% Ficoll, 20 mM HEPES, 1 mM EDTA, 0.5 mM DTT, 1 mg poly dI : dC) and 25 fmol of biotin-labelled oligonucleotide for 30 min on ice. Oligonucleotides encompassed the TATA box (plus 59-CCGG-ACACTATTTAAGGGCCCGCCTCTCCTGG-39 and minus 59-CCAGGAGAGGCGGGCCCTTAAATAGTGTCCGG-39), the putative SP1 site (plus 59-TTAAGGGCCCGCCTCTCCT-GGCTCACAGCTGC-39 and minus 59-GCAGCTGTGAGCC-AGGAGAGGCGGGCCCTTAA-39) or the TSS incorporating the major (plus 59-CCGCCTCTCCTGGCTCACAGCTGCTT-GCTGCT-39 and minus 59-AGCAGCAAGCAGCTGTGAGC-CAGGAGAGGCGG-39) or the minor (plus 59-CCGCCTCTC-CTGGCTCATAGCTGCTTGCTGCT-39 and minus 59-AGCA-GCAAGCAGCTATGAGCCAGGAGAGGCGG-39) allele of rs182309299. For competition reactions, cold competitor was incubated with nuclear extract for 10 min. For supershift assays, 2 mg of a-SP1 (Abcam) or a-TBP (Abcam) was incubated for 30 min prior to addition of labelled oligonucleotide. Binding reactions were electrophoresed in pre-cast 6% DNA retardation gels (Life Technologies, Mulgrave, VIC, Australia) at 100 V for 60 min, transferred to a nylon membrane at 30 V for 60 min. Protein-DNA complexes were visualized with the Chemiluminescent Nucleic Acid Detection Module (Thermo FISHER Scientific, Scoresby, VIC, Australia).
Identification of putative core promoter elements
The 250 to 150 region of the CR2/CD21 promoter was manually interrogated for sequences with similarity to known core promoter motifs including TATA box, Inr, upstream or downstream TFIIB recognition element (BRE U and BRE D ), motif ten element and DPE at consensus locations. Putative transcription factor binding sites were identified using the LASAGNAsearch web tool. 35 Flow cytometry Cultured B-cell lines were harvested and 1310 6 cells washed twice with cold staining buffer (PBS containing 5% FBS) at 300g for 5 min at 4 uC. Cells were resuspended in 80 mL staining buffer and incubated with 20 ml of PE-conjugated mouse antihuman CD21 antibody (555422; BD Biosciences, San Jose, CA, USA) or PE-conjugated mouse IgG1k isotype control (BD Biosciences, 551436), for 20 min. Unstained cells were also included. Cells were washed twice, resuspended in 0.5 ml staining buffer and analysed using a BD Accuri C6 flow cytometer (BD Biosciences) and FlowJo software V10.0.5 (Tree Star, Ashland, OR, USA).
Rapid amplification of cDNA ends (RACE) 59RACE was optimized and performed based on the ScottoLavino et al. 36 new RACE protocol with modifications. Total mRNA was prepared from 1310 7 cells using RNAzol RT (Sigma Aldrich, St Louis, MO, USA), dephosphorylated with 20 U CIP (New England Biolabs, Ipswich, MA, USA) and mRNA cap removed using 0.5 U TAP (Epicentre Biotechnologies, Madison, WI, USA). An RNA oligonucleotide (59-CGACUGAAGCACGAGGAUAUUGACAUGGACUGAA-GGAGUAGAAA-39) was added using 10 U T4 RNA ligase (New England Biolabs). RNA was incubated with 2.5 fmol gene-specific reverse primer and annealing buffer (0.25 M NaCl, 6.25 mM EDTA, 50 mM Tris-Cl pH 7.5), for 5 min at 65 uC, snap cooled and incubated for 4 h at 40 uC. RNA was reverse transcribed using the SuperScript VILO cDNA Synthesis Kit (Life Technologies). Primary PCR (FWD 59-CGACTGAAGCACGAGGATATTGA-39, REV 59-GGAGCAA-TGGAGCCAACATT-39, annealing temperature 55 uC) was followed by two nested reactions (REV 59-CGGCCCCCACAT-ATTATTT-39, annealing temperature 55 uC and FWD 59-GGATATTGACATGGACTGAAGGAGTA-39, REV 59-GGGT-GTAGAGCCTCTAATTTT-39, annealing temperature 54 uC). PCR was performed using the PTC-100 Thermocycler (MJ Research, Waltham, MA, USA) and GoTaq green master mix (Promega, Madison, WI, USA). Briefly, 1 ml template was amplified in 50 ml reactions with 0.2 mM each primer. PCR products were electrophoresed on a 1.5% agarose gel stained with ethidium bromide. Amplicons were cloned using the TOPO-TA cloning kit (Life Technologies) and sequenced.
Transfection and quantitation of promoter activity
The luciferase reporter containing 21250/175 (1.2 LUC) of the CR2/CD21 promoter was prepared as described previously. 25 Bioinformatics were generated with LASAGNE-Search 2.0 35 and site-directed mutagenesis was performed using the QuikChange mutagenesis kit (Stratagene, La Jolla, CA, USA). Plasmid DNA was prepared using the EndoFree Plasmid Maxi kit (QIAGEN, Valencia, CA, USA) followed by transient transfection with the Amaxa Nucleofector Device and Cell Line Nucleofector Solution V (Lonza, Basel, Switzerland). Cell lysates were sequentially assayed for Firefly and Renilla luciferase using the Dual-Luciferase Reporter Assay system (Promega). Luminescence was analysed using Tropix Winglow software (Applied Biosystems, Foster City, CA, USA). Firefly luciferase was normalized to Renilla luciferase and the activity of each mutant was normalized to the wild-type 1.2 LUC plasmid.
Statistical analysis
Differences in transcriptional activity or ChIP enrichment were assessed using Student's paired t-test with a confidence interval of 95% (P,0.05). Statistics and graphs were generated using GraphPad Prism version 5.0 (GraphPad, San Diego, CA, USA).
All graphed values represent the mean6SEM of at least three independent experiments. 1 primary human B cells, which were freely available from the ENCODE server. 39 The vast majority of CAGE tags aligned to a narrow region (25 bp) downstream to the major TSS identified previously (Figure 1c ), however, a small number of CAGE tags mapped to a broader 100 bp region either side of the major TSS. Shorter fragments are potentially an artefact of RNA quality or methodology, but could indicate the presence of minor start sites in B cell subpopulations. Our results and those of others 37, 38 indicate that transcription of CR2/CD21 is focused around a single peak spanning approximately 30 bp.
RESULTS
Transcription of
The CR2/CD21 core promoter contains putative TATA, Inr, DPE and GC box motifs We next identified potential core promoter elements and transcription factor binding sites surrounding the TSS (Figure 2a) . A non-consensus Inr (CR2/CD21; ACAGCTG, consensus; PyPy-A 11 -N-T/C-Py-Py) was identified that was spatially aligned with a TATA-like element (CR2/CD21; TATTTAAG, consensus; TATAWAWA) located at 229 to 222 relative to the A 11 in the putative Inr. A GC box potentially bound by SP1 (CR2/CD21; GGGCCC, consensus; GGGCGG) was identified directly downstream and slightly overlapping the TATA-like element. A putative DPE was also identified with a near-consensus sequence (CR2/CD21; AGAGC, consensus; A/G-G-A/ T-C/T-A/C/G) located at 131 to 135 and predicted to bind E2A. E2A is associated with gene expression changes during Bcell development 40 and is essential for the development of pro-, pre-and immature B cells in the bone marrow. 41 To determine if E2A is bound to the CR2/CD21 gene encompassing the DPE in mature B cells, we performed chromatin immunoprecipitation with antibodies specific for the E2A proteins E12 and E47 as well as RNAP as a positive control (Figure 2b ). Using Ramos cells, robust enrichment of E12, E47 and RNAP could be detected upstream of the CR2/CD21 TSS (Figure 2b , n52).
TATA box, Inr and DPE sequences contribute to transcriptional regulation of the CR2/CD21 promoter To test the functionality of putative core promoter elements, luciferase assays were performed using various mutants of the 21250/175 CR2/CD21 promoter ( Figure 3a) . Robust activation of the wild-type (WT) promoter was observed when transfections were performed in Raji cells. Mutation of the TATA box, Inr or DPE sequences resulted in a significant 30%-40% decrease in 1.2 LUC promoter activity (Pf0.01) (Figure 3b ). The 222/220 mutation resulted in reduced luciferase activity comparable to that of the adjacent TATA box mutation, while the overlapping 221/217 mutant had no effect, suggesting that the guanine (G) residue which forms the overlap between the TATA box and SP1 site, is critical for TATA box function. Mutation of the GC box at either two (SP1 2 bp), or five (SP1 5 bp) nucleotides had no effect. As mutation of a single promoter element was insufficient to abolish transcriptional activity, we hypothesized that transcription is regulated by a synergistic combination of elements. Concomitant mutation of the TATA and GC boxes resulted in a 50% reduction in luciferase activity compared to the WT promoter (P,0.001) (Figure 3c ), but was not significantly different from mutation of the TATA box alone. Simultaneous mutation of the TATA box and Inr element decreased transcriptional activity by 65% (P,0.0001), and was significantly reduced compared to the individual TATA (P,0.001) and Inr (P,0.01) mutants. As the effects of the individual TATA and Inr mutations were not additive, we conclude that these two elements do not function independently. Additional mutation of the DPE did not further reduce transcriptional activity. Similar results were observed when transfections were performed in the CR2-and EBV-negative cell line K562 (Figure 3d and e).
Sequence-specific protein-DNA complexes containing TBP and SP1 interact with 226 to 16 of the CR2/CD21 promoter in vitro To delineate the transcription factor binding sites spanning the TATA box (TATA probe, 237 to 26) and putative SP1 site (GC box probe, 226 to 16) partially overlapping oligonucleotides were designed (Figure 4a ). When electrophoretic mobility shift assays (EMSA) was performed with CR2-negative (K562, Reh) or CR2-positive (Ramos, Raji) nuclear extract, three protein-DNA complexes were detected in the presence of the TATA oligonucleotide (I, III, IV) and four major complexes bound to the GC box oligonucleotide (I -IV) (Figure 4b ). All complexes formed resulted from specific protein-DNA interactions, as they were successfully out-competed by a 30-to 60-fold excess of unlabeled oligonucleotide (Figure 4b ). Supershift assays performed with Raji nuclear extract using either a-TBP or a-SP1 with the TATA oligonucleotide did not yield any differences in complex formation (Figure 4c, lanes 2-4) . When similar supershift assays were performed with the GC oligonucleotide, addition of a-TBP resulted in a decrease in complex B (Figure 4c Figure 2 The CR2/CD21 promoter contains near consensus sequences matching TATA box, GC box, Inr and DPE motifs. (a) The CR2/CD21 promoter sequence spanning 250/150 relative to the TSS (curved arrow) was manually interrogated for sequences matching known core promoter elements. Identity to TATA box (222/229), GC box (217/222), Inr (22/15) and DPE (131/135) motifs is demonstrated with vertical lines between the CR2/CD21 promoter sequence and the consensus sequence (black box). The LASAGNE-search web tool was used to predict binding of TBP, SP1 and E2A to the TATA box, GC box and DPE, respectively. (b) Binding of E2A (E12 and E47) to the CR2/CD21 gene surrounding the DPE was confirmed in Ramos cells by chromatin immunoprecipitation (n52). Enrichment generated by antibodies specific for E12, E47 and the positive control (RNAP) was quantified by comparison to serially diluted chromatin input (10%-0.01%) and normalized to the enrichment generated by the IgG control. Representative qPCR amplicons were run on a 1.5% agarose gel stained with ethidium bromide to ensure reaction specificity. No specific enrichment was generated in the no antibody control sample (No Ab) and no PCR amplicons were detected in the NTC. CR2/ CD21, complement receptor 2; DPE, downstream promoter element; NTC, no template control; TSS, transcriptional start site.
Occupancy of general transcriptional machinery at the CR2/ CD21 promoter corresponds to CR2/CD21 expression level and development stage As CR2/CD21 is upregulated upon B-cell maturation, we hypothesized that the core promoter is poised for transcriptional activation at the pre-B-cell stage. To investigate this, we performed ChIP using antibodies specific for TBP, SP1 and RNAP phosphorylated at either serine 2 (RNAPpS2) or serine 5 (RNAPpS5). CR2/CD21 non-expressing pre-B (Reh), or terminally differentiated B (SKW) and CR2/CD21-expressing mature B (Ramos and Raji) cell lines were used to assess general transcriptional machinery occupancy at the CR2/CD21 promoter during B-cell development. The status of CR2/ CD21 surface expression for each cell line was confirmed by flow cytometry. In the Reh and SKW cell lines, which do not express CR2/CD21, no significant enrichment was generated with any of the antibodies tested (Figure 5a and d) , indicating that CR2/CD21 is not poised for transcriptional activation prior to induction of CR2/CD21 expression or after cells have undergone terminal differentiation. In both mature B-cell lines, TBP and RNAPpS5 could be detected at the CR2/CD21 promoter (P,0.05) (Figure 5b and c) . Consistently, the levels of enrichment generated by TBP and RNAPpS5 were higher in Raji than Ramos cells, and correlated with CR2/CD21 expression. Capture of RNAPpS2 at the CR2/CD21 promoter was slight in both Raji and Ramos, whereas the results for anti-SP1 differed between the mature B-cell lines. In Ramos cells, anti-SP1 enrichment was on average sevenfold greater than the isotype control, however this was not observed for Raji cells. Interestingly, although SP1-specific pull-down in Ramos cells did not reach statistical significance, a significant negative correlation was observed between enrichment of SP1 and RNAPs5 within each biological replicate (P,0.05, R 2 50.91) (Figure 5e ). Therefore, higher levels of RNAPpS5 appear to correlate with lower levels of SP1 enrichment and this is consistently observed in the Raji samples. 2 and EBV-negative K562 cells, mutation of the GC box and Inr sequence resulted in a 50% reduction in luciferase activity compared to the WT promoter. (e) In K562 cells, concomitant TATA-SP1 mutation resulted in a 50% reduction in luciferase activity, while TATA-INR mutation resulted in a 65% decrease in luciferase activity but tripartite mutation of TATA-INR-DPE did not reduce luciferase activity below 25% of the WT promoter. Data are the results of three independent replicates presented as mean6SEM Significance is indicated by *P,0.05, **P,0.005 and ***P,0.0005. CR2/ CD21, complement receptor 2; DPE, downstream promoter element; EBV, Epstein-Barr virus; Inr, initiator element; WT, wild-type.
The CR2/CD21 promoter is unmethylated and enriched for activating histone marks in CD20
1 human B cells We have previously shown that chromatin accessibility surrounding the CR2/CD21 TSS also correlates with CR2/CD21 expression status in the model cell lines K562, Reh, Ramos, Raji and SKW. 34 In addition, enrichment of histone H3/H4 acetylation and H3K4 dimethylation was also correlated with CR2/ CD21 expression status in Reh, Ramos and Raji cells. 34 To determine if these results are representative of primary human cells, we interrogated the ENCODE database for enrichment of histone modifications and CpG dinucleotide methylation in CD20 1 or EBV-immortalized peripheral blood B-cells ( Figure 6 ). In general, enrichment of histone modifications associated with active transcription (H3K4m2, H3K27ac, H3K4m3, H3K9ac, H3K79m2) 42 was greater in CD20 1 or EBV-immortalized peripheral blood B cells than in the CR2/ CD21-negative cell line K562 ( Figure 6, red box) . Further, CpG dinucleotides surrounding the CR2/CD21 TSS in peripheral blood B-cells were unmethylated, while CpG dinucleotides were frequently methylated in K562 cells ( Figure 6 , blue box).
The minor allele of rs182309299 is associated with increased CR2/CD21 transcript abundance in mature B-cell lines but does not alter protein-DNA interactions Genetic variants in the core promoter potentially contribute to differential transcriptional regulation and gene expression. We have previously reported the transcriptional effects of the SNP rs3813946 in the core promoter of CR2/CD21, which alters chromatin accessibility and transcription factor binding. 43 We identified a second SNP, rs182309299 (C.T), located at the 21 position of the CR2/CD21 gene that we hypothesized could affect Inr activity, since single nucleotide variations located at 21 to 13 can result in differences in promoter activity of up to ninefold. 44, 45 Therefore, we performed luciferase assays in Raji cells using a 21250/175 CR2/CD21 promoter construct expressing either the major or minor allele of the 21 C.T SNP. Expression of the minor allele (21T) resulted in significantly higher luciferase activity when compared to the major allele (21C) (P,0.001) (Figure 7a) . Similar results were observed in the CR2/CD21 2 and EBV-negative cell line K562 (Figure 7b ). To determine if altered transcriptional activity was mediated by altered protein-DNA interactions, we performed EMSA analysis using oligonucleotides spanning the TSS (218 to 114) and containing either the C or T allele of rs182309299. Using K562, Reh, Ramos and Raji nuclear extracts, we detected two weak sequence-specific protein-DNA complexes (Figure 7c ). These complexes correspond to complexes I and IV (Figure 4b and c) previously observed to bind directly upstream of the TSS; however, complex formation did not differ between the alleles.
DISCUSSION
The dynamics of core promoter regulation are made possible by the integrated interaction between nucleotide sequence, core-promoter-element spacing, epigenetic regulation and Test  15X  30X  60X  UB  Test  15X  30X  60X  UB  Test  15X  30X  60X  UB  Test  15X  30X  60X  UB  Test  15X  30X  60X  UB  Test  15X  30X  60X  UB  Test  15X  30X  60X 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 three dimensional conformation. 28, [46] [47] [48] Here we discuss the complex core promoter regulation of CR2/CD21, the expression of which is cell type-specific and inducible.
We have identified core promoter elements in the CR2/CD21 core promoter including TATA box, GC box, Inr and DPE sequences. This core promoter architecture is of interest as the combination of TATA, Inr and DPE is rare in human promoters. While human genes containing DPE have been identified, 49, 50 very few functional studies on human DPEs have been carried out. [51] [52] [53] [54] Interestingly, all of the human DPEs so far characterized are found in genes containing functional Inr elements and in close proximity to an SP1 site. 49, [51] [52] [53] [54] We find that no single element is capable of directing CR2/ CD21 transcription initiation, although the TATA box and Inr Figure 5 Occupancy of RNAPpS5 at the CR2/CD21 promoter correlates to CR2/CD21 expression level in vivo. CR2/CD21 cell-surface expression was determined by flow cytometry (upper panel). Specific enrichment of the CR2/CD21 promoter (middle panel) was observed in mature B-cell samples Ramos (b) and Raji (c) immunoprecipitated with TBP and RNAPpS5. Specific enrichment of SP1 was only generated in Ramos samples (b), and was negatively correlated with RNAPpS5 enrichment (e). No specific enrichment was generated in CR2/CD21-negative Reh (a) or SKW (d) with any antibodies tested. Enrichment was quantified by comparison to serially diluted chromatin input (10%-0.01%). A representative sample from each cell line was run on a 1.5% agarose gel (lower panel). Graphs were generated from three independent experiments and represent the mean6SEM Significance is indicated by *P,0.05, **P,0.005 and ***P,0.0005. CR2/CD21, complement receptor 2.
function synergistically in regulating CR2/CD21 transcription. We show that the DPE contributes to transcriptional regulation but does not act in conjunction with the TATA and Inr elements in vitro. The 257/175 region of CR2/CD21 core promoter has previously been shown to direct cAMP inducible expression of CR2/CD21 in vitro. 23 The DPE may be involved in regulating inducible expression of CR2/CD21 as the specific elements mediating this effect have not been defined. Consistent with this, the MHC class I gene promoter contains a TATA box, an Inr, a DPE and an SP1 binding site, none of which are strictly necessary for transcription. 53, 54 Rather, each element uniquely regulates tissue-specific or inducible expression levels accordingly.
The role of the GC box is harder to interpret as our EMSA analyses suggest that SP1 competes for binding with unidentified factors bound to the adjacent TATA box, a feasible possibility since the two binding sites overlap by a single nucleotide. Further, our ChIP data show an inverse correlation between SP1 and RNAPpS5, consistent with binding site competition. However, since our luciferase assays indicate that the GC box does not control basal levels of transcript abundance, the role of this element may be mechanical. For example, it has been suggested that constitutive SP1 binding to the core promoter of the Lymphotoxin-a gene in T cells is required to maintain the promoter in an accessible conformation in the absence of TFII-I and RNAP. 55 Further, SP1 is known to interact with both histone acyltransferase 56 and histone deacetylase 57 and may therefore be involved in regulating the chromatin conformation surrounding the TSS. Such interactions would not likely have an effect on reporter gene expression, but may be important to the regulation of inducible gene expression requiring rapid transcript upregulation upon receiving a specific biological signal.
We mapped the major CR2/CD21 TSS in mature B-cell lines to a single nucleotide located within the Inr. This observation is in line with the current view that tissue-specific and developmentally regulated genes are more likely to be controlled by core promoter elements (TATA, Inr, DPE) and initiate transcription at a single precise location or narrow window. 26, 58 This is supported by primary cell data which show that in the major population of peripheral blood B cells, CR2/CD21 transcription initiates from a focused TSS (ENCODE). However, a small population of CD20 1 CAGE tags initiated transcription over a broader 100 bp range. Since CD20 1 cells encompass the entire B-cell pool ranging from late pro-B to mature B, it is possible that minor start sites may be utilized in specific B-cell subsets.
We find that general transcription factor occupancy surrounding the major TSS correlates with CR2/CD21 expression level in pre-B-and mature B-cell lines. It has been suggested that developmentally regulated genes are enriched for poised promoters, while tissue-specific genes are more likely to be strictly active or inactive. 59 However, inducible promoters of the broad peak class are also frequently poised for transcription. 60 We did not find any evidence that CR2/CD21 is poised prior to B cell maturation. These results are supported by chromatin accessibility assays which show that in CR2/CD21 expressing cell lines Ramos and Raji, chromatin is significantly more accessible compared to the CR2/CD21 non-expressing cell line Reh. 34 Chromatin was also more accessible directly surrounding the transcriptional start site in Raji cells compared to Ramos cells. 34 Therefore, CR2/CD21 expression level correlates with chromatin accessibility and general transcription factor occupancy which suggests that between the pre-B-and mature B-cell stages, the CR2/CD21 promoter switches from strictly inactive to active and requires significant chromatin rearrangement.
rs182309299, located at 21, modifies the transcriptional activity of the CR2/CD21 core promoter. Since phenotypic differences in gene expression between populations can be attributed to differences in frequencies of genetic variants, 61 it is possible that rs182309299 contributes to variation in CR2/CD21 expression levels between populations. Genotyping performed through the 1000 Genomes Project Phase 1 demonstrated the minor allele of this SNP is detected only in 1%-2% of individuals of African or African-American ancestry (Ensembl release 76, August 2014).
The retention of this variant in individuals of African descent could confer a functional benefit, potentially relevant to a specific immunological challenge. We did not detect differences in protein binding between the two alleles of rs182309299 in vitro despite a threefold increase in transcriptional activity associated with the minor allele. These data suggest that sequence variants in the core promoter may regulate the structural dynamics of transcription. The major allele of rs182309299 is present in a complementary tri-nucleotide pair CA 11 G-CTG which scores among the highest for bendability and flexibility compared to all trinucleotide combinations assessed by DNase I accessibility and nucleosome position matrices. 46 The minor allele disrupts this complementarity (TA 11 G-CTG) and could therefore alter the curvature of the DNA directly surrounding the transcriptional start site. Similarly, point mutations surrounding a Super-core Promoter TSS that did not alter transcription factor binding in vitro resulted in a fourfold decrease in reporter gene activity, which was attributed to a decreased seeding of TSS bubble formation. 62 It is likely that DNA structural dynamics act in conjunction with TF binding. The promoters' structural 33-35 and 38-40) . Results were generated from three independent experiments and graphs are represented as mean6s.e.m. Significance is indicated by *P,0.05 and **P,0.005. EMSA, electrophoretic mobility shift assay.
properties seed the 3D conformation required for initiation, which simultaneously enhances recognition of DNA sequence motifs required for TF assembly and directing TSS placement and strength.
CONCLUSION
Using human B-cell lines frozen at specific stages of B-cell development, we show a marked difference in promoter accessibility and RNAP occupancy surrounding the CR2/CD21 core promoter in pre-B versus mature B cells. Based on the results presented here, we propose that consensus motifs in the CR2/ CD21 core promoter become accessible during B cell ontogeny via chromatin rearrangement, allowing a developmental switch from inactive to active and recruitment of the general transcriptional machinery (Figure 8 ). The precise stage of transitional B cell development (T1-T3) at which chromatin remodeling occurs, and the developmental signals driving this transition, remain to be defined. Subsequently, synergistic activity of TATA and Inr efficiently positions RNAP to direct transcription from a focused TSS, while inducible expression of CR2/ CD21 may be modified by TF interactions with GC box and DPE motifs. Lastly, we highlight the potential for single nucleotide variants in the core promoter to contribute to transcriptional regulation and variation in gene expression between populations. 
